2/2 Collaborative Union for Cancer Research, Education, and Disparities (CURED)

2/2 癌症研究、教育和差异合作联盟 (CURED)

基本信息

  • 批准号:
    10762045
  • 负责人:
  • 金额:
    $ 28.56万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-09-21 至 2027-08-31
  • 项目状态:
    未结题

项目摘要

CURED Overall Abstract Dan L Duncan Comprehensive Cancer Center (DLDCCC) at Baylor College of Medicine (BCM) and Texas Southern University (TSU) are jointly submitting a P20 application to build a collaborative partnership in cancer research, education, and outreach. DLDCCC is a National Cancer Institute (NCI) designated cancer center. TSU is one of the nation’s largest Historically Black Colleges and Universities (HBCU) serving underserved populations and underrepresented students (ISUPSs). BCM and TSU have had several successful collaborations. This relationship was strengthened recently through TSU’s U54 “Center for Biomedical and Minority Health Research”, where BCM faculty have partnered closely on collaborative cancer disparities community education and outreach. This P20 program provides an excellent opportunity for TSU and BCM to expand collaborations. We propose a BCM-TSU P20 program “Collaborative Union for Cancer Research, Education and Disparities” (CURED) that will foster strong collaborations utilizing our complementary strengths. Overall objectives are to create a shared infrastructure that will provide an optimal environment for cancer research, education, community outreach, and career development and diversify the biomedical workforce. CURED was established under the direction of senior leadership at each institution, reflected in the significant institutional support for this partnership. BCM has committed $160,000/year for four years in cost matching funds, $ 50,000 for Pilot project 2 for one year, and committed funds to support the training of TSU summer students in the Cancer Research Education Program. TSU has committed to return the Indirect Cost allocation amounting to $98,000 each year. All TSU investigators are members of the DLDCCC. Leaders of each institution are thus committed to empower the P20 partnership to address cancer health disparities among URM and underserved populations in Houston. Our goals are to (1) establish a collaborative alliance between BCM and TSU for cancer research, education, and community outreach. We will (a) establish CURED offices in both institutions that will provide coordination for relevant activities, evaluate progress of current projects, and ensure a pipeline of innovative pilot projects; (b) centralize institutional resources for faculty/trainee research needs (c) lead a cancer research and career development program for TSU students that includes mentored cancer research, an educational curriculum, hands-on training in emerging technologies, and professional development; (d) build a BCM/TSU comprehensive outreach program to address cancer disparities at the bench, bedside, and within the community; and (2) to support a pipeline of collaborative innovative cancer research pilot projects. Overall Impact: We are certain that the proposed CURED will enhance cancer research education capacity at TSU, promote a diverse research workforce, and improve BCM/DLDCCC’s effectiveness in developing and sustaining research programs focused on cancer health disparities. We will develop sustainable research capacity leading to independent and collaborative applications to the NIH/other Federal/Non-federal agencies.
总体摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Veronica B Ajewole其他文献

Veronica B Ajewole的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Veronica B Ajewole', 18)}}的其他基金

1/2 Collaborative Union for Cancer Research, Education and Disparities (CURED)
1/2 癌症研究、教育和差异合作联盟 (CURED)
  • 批准号:
    10762265
  • 财政年份:
    2023
  • 资助金额:
    $ 28.56万
  • 项目类别:
BCM/TSU P20 Collaborative Union for Cancer Research, Education and Disparities (CURED) Administrative Core (AC)
BCM/TSU P20 癌症研究、教育和差异合作联盟 (CURED) 行政核心 (AC)
  • 批准号:
    10762046
  • 财政年份:
    2023
  • 资助金额:
    $ 28.56万
  • 项目类别:
CBMHR Community Engagement Core
CBMHR 社区参与核心
  • 批准号:
    10426331
  • 财政年份:
    1986
  • 资助金额:
    $ 28.56万
  • 项目类别:
CBMHR Community Engagement Core
CBMHR 社区参与核心
  • 批准号:
    10676837
  • 财政年份:
    1986
  • 资助金额:
    $ 28.56万
  • 项目类别:
CBMHR Community Engagement Core
CBMHR 社区参与核心
  • 批准号:
    10271286
  • 财政年份:
    1986
  • 资助金额:
    $ 28.56万
  • 项目类别:

相似海外基金

Advisory Committees
咨询委员会
  • 批准号:
    7353899
  • 财政年份:
    2006
  • 资助金额:
    $ 28.56万
  • 项目类别:
Toward a Political Theory of Bioethics: Participation, Representation, and Deliberation on Federal Bioethics Advisory Committees
迈向生命伦理学的政治理论:联邦生命伦理学咨询委员会的参与、代表和审议
  • 批准号:
    0451289
  • 财政年份:
    2005
  • 资助金额:
    $ 28.56万
  • 项目类别:
    Standard Grant
Advisory Committees
咨询委员会
  • 批准号:
    7557224
  • 财政年份:
  • 资助金额:
    $ 28.56万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    7902286
  • 财政年份:
  • 资助金额:
    $ 28.56万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    7691385
  • 财政年份:
  • 资助金额:
    $ 28.56万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    8150373
  • 财政年份:
  • 资助金额:
    $ 28.56万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了